v3.22.2.2
Note 1 - Description of Business (Details Textual)
3 Months Ended 6 Months Ended
Jun. 24, 2021
shares
Jun. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Jun. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Number of Subsidiaries           2    
Cash and Cash Equivalents, at Carrying Value, Total   $ 553,754       $ 553,754   $ 1,844,732
Retained Earnings (Accumulated Deficit), Total   (140,726,745)       (140,726,745)   $ (129,482,141)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total   $ (3,490,547) $ (7,759,933) $ (6,605,145) $ (5,286,646) $ (11,250,480) $ (11,891,791)  
ImQuest [Member]                
Conversion of Stock, Shares Converted (in shares) | shares 12,000,000              
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares 3,282,089              
BioLab 612 [Member]                
Number of Wholly Owned Subsidiaries           1    
GPI [Member]                
Equity Method Investment, Ownership Percentage   50.00%       50.00%